PUBLIC LAW 94-278—APR. 22, 1976 (ii) the ability of peer review systems to insure high quality federally funded research; and (iii) the (I) protection of the public against research which presents an unreasonable risk to human subjects of such research and (II) the adequacy of informed consent procedures. (2)(A) Not later than May 31, 1976, the Panel shall complete the investigation and study required to be made by the Panel by paragraph (1), and, not later than June 30, 1976, the Panel shall submit to the Committee on Interstate and Foreign Commerce of the House of Representatives and the Committee on Labor and Public Welfare of the Senate a report on such investigation and study. The report shall contain such recommendations for legislation as the Panel deems appropriate. (B) Not later than November 30, 1976, the Commission shall complete the investigation and study required to be made by the Commission by paragraph (1), and, not later than December 31, 1976, the Commission shall submit to the Committee on Interstate and Foreign Commerce of the House of Representatives and the Committee on Labor and Public Welfare of the Senate a report on such investigation and study. The report shall contain such recommendations for legislation as the Commission deems appropriate. (b) Section 211(b) of the National Eesearch Act (Public Law 93-348) is amended by striking out "July 1, 1976" and inserting in lieu thereof "January 1, 1977".
90 STAT. 407
Report to congressional committees.
Report to congressional committees.
42 USC 218 note.
TITLE IV—GENETIC DISEASES SEC. 401. This title may be cited as the "National Sickle Cell Anemia, Cooley's Anemia, Tay-Sachs, and Genetic Diseases Act". SEC. 402. In order to preserve and protect the health and welfare of all citizens, it is the purpose of this title to establish a national program to provide for basic and applied research, research training, testing, counseling, and information and education programs with respect to genetic diseases, including sickle cell anemia, Cooley's anemia, TaySachs disease, cystic fibrosis, dysautonomia, hemophilia, retinitis pigmentosa, Huntington's chorea, and muscular dystrophy. SEC. 403. (a) Title X I is amended by striking out parts A and B and inserting in lieu thereof the following:
National Sickle Cell Anemia, Cooley's Anemia, Tay-Sachs, and Genetic Diseases Act 42 USC 300b note. 42 USC 300b note.
"PART A—GENETIC DISEASES TESTING AND COUNSELING PROGRAMS AND INFORMATION AND EDUCATION PROGRAMS
"SEC. 1101. (a)(1) The Secretary, through an identifiable admin- 42 USC 300b. istrative unit within the Department of Health, Education, and Welfare, may make grants to public and nonprofit private entities, and may enter into contracts with public and private entities, for projects to establish and operate voluntary genetic testing and counseling programs primarily in conjunction with other existing health programs, including programs assisted under title V of the Social Security Act. 42 USC 701. "(2) The Secretary shall carry out, through an identifiable administrative unit within the Department of Health, Education, and Welfare, a program to develop information and educational materials
�
